Kingfa Science & Technology (India) Ltd
Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves. [1]
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has delivered good profit growth of 44.1% CAGR over last 5 years
- +Company's median sales growth is 25.6% of last 10 years
Weaknesses
- −Promoter holding has decreased over last 3 years: -7.97%
Shareholding Pattern
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 67.02%▼8.0 | 67.02% | 67.02% |
| FIIs | 6.34% | 6.35%▲0.0 | 6.35% | 6.35% | 6.34%▼0.0 | 7.78%▲1.4 | 7.74%▼0.0 | 7.76%▲0.0 |
| DIIs | 0% | 0.04%▲0.0 | 0%▼0.0 | 0.17%▲0.2 | 0.15%▼0.0 | 8.75%▲8.6 | 8.75% | 8.85%▲0.1 |
| Public | 18.67% | 18.61%▼0.1 | 18.65%▲0.0 | 18.47%▼0.2 | 18.51%▲0.0 | 16.45%▼2.1 | 16.5%▲0.1 | 16.36%▼0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 |
| Expenses | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 |
| Operating Profit | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 |
| OPM % | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% |
| Net Profit | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 |
| EPS ₹ | 24.44 | 20.09 | 27.7 | 32.26 | 30.77 | 28.6 | 34.6 | 32.86 | 30.36 | 33.33 |
AI Insights
TTM revenue at ₹1,887Cr, up 8.1% YoY. OPM at 13%.
Borrowings at ₹19Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.
CWIP at ₹45Cr (16% of fixed assets). Moderate ongoing capital expenditure.
DIIs: 8.85% (+8.85pp change). FIIs: 7.76% (+1.42pp change). Promoters hold 67.02%.
ROCE improving from -9% (Mar 2014) to 31% (Mar 2025). Working capital days: 85.
PE 41.9x with 30.6% ROCE. Price is 445% above book value of ₹955. Dividend yield: 0%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Monitoring Agency Report 13 May - CARE report for Q4FY26 shows no deviation in Rs500 crore preferential issue; Rs155.78 crore utilized.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 17 Apr - Kingfa says it is not a Large Corporate Entity for FY 2025-26.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026.
- Closure of Trading Window 25 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results; board meeting date pending.
- Announcement Under Regulations 30 Of SEBI LODR Regarding Commencement Of Commercial Production 23 Feb - Kingfa's Bhiwadi unit (Plot C-583 series) commenced commercial production effective 22 February 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse